Yang M, Yue H, Xu Q, Shao S, et al. Pioglitazone reduces serum ketone bodies in sodium-glucose cotransporter-2 inhibitor-treated non-obese type 2 diabetes: A single-centre, randomized, crossover trial. Diabetes Obes Metab 2024 May 3. doi: 10.1111/dom.15641.
PMID: 38699792